title: Clinical management of tacrolimus drug interactions in renal transplant patients.
authors.affiliation: Nephrology and Biochemistry Service, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Moreno
authors.forename: A
authors.initials: A
authors.lastname: Latorre
authors.forename: C
authors.initials: C
authors.lastname: Manzanares
authors.forename: E
authors.initials: E
authors.lastname: Morales
authors.forename: J C
authors.initials: JC
authors.lastname: Herrero
authors.forename: B
authors.initials: B
authors.lastname: Dominguez-Gil
authors.forename: A
authors.initials: A
authors.lastname: Carreño
authors.forename: A
authors.initials: A
authors.lastname: Cubas
authors.forename: M
authors.initials: M
authors.lastname: Delgado
authors.forename: A
authors.initials: A
authors.lastname: Andres
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
mesh_terms: D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects*; D002177:Candidiasis / Q000188:drug therapy; D004347:Drug Interactions; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000097:blood; D007654:Ketoconazole / Q000009:adverse effects*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D010672:Phenytoin / Q000627:therapeutic use; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood
chemical_list: D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D010672:Phenytoin; D004917:Erythromycin; D007654:Ketoconazole; D012293:Rifampin; D016559:Tacrolimus